【24h】

Patient and technique survival on CAPD in Turkey.

机译:土耳其CAPD患者和技术的生存率。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To analyze the status of continuous ambulatory peritoneal dialysis (CAPD) in 12 centers in Turkey. DESIGN: Retrospective study of CAPD technique and patient outcome. SETTING: University hospital renal units. PATIENTS: 334 patients [205 males (61%),129 (39%) females; mean age 42.2 +/- 13.8 years; mean follow-up time 23.5 +/- 18.3 months] beginning CAPD between March 1992 and December 1999, and having a minimum follow-up of 3 months. OUTCOME MEASURE: Patient survival, technique survival, and duration of hospitalization. RESULTS: Mean weekly Kt/V urea was 1.9 +/- 0.8, weekly creatinine clearance was 62.9 +/- 8.5 L/1.73 m2, and mean serum albumin level was 3.7 +/- 0.6 g/dL. 93 patients (28%) were withdrawn from peritoneal dialysis due to death (12.6%), transplantation (3.9%), transfer to hemodialysis (8.7%), patient failure to adapt (1.5%), and other reasons (1.2%). The major causes of death were cardiovascular disease (60%), infection (19%), malignancy (2%), and others (19%). Cox proportional hazard model analysis indicated age, serum albumin levels, comorbidity, and functional status affected survival and hospitalization (p < 0.05), whereas gender and Kt/V did not (p > 0.05). Estimation of patient survival by Kaplan-Meier analysis showed 94.2%, 88.6%, 84.5%, and 68.9% at 1, 2, 3, and 5 years respectively. Technique survival estimate by Kaplan-Meier analysis was 96.6%, 91.1%, 90.4%, and 77.4% at 1, 2, 3, and 5 years respectively. CONCLUSION: Peritoneal dialysis is an acceptable method of renal replacement therapy in Turkey. There is controversy regarding the usefulness of Kt/V in predicting mortality and morbidity.
机译:目的:分析土耳其12个中心的持续非卧床腹膜透析(CAPD)的状况。设计:CAPD技术和患者预后的回顾性研究。单位:大学医院肾脏科。患者:334名患者[205名男性(61%),129名(39%)女性;平均年龄42.2 +/- 13.8岁;平均随访时间23.5 +/- 18.3个月]从1992年3月至1999年12月开始CAPD,且至少随访3个月。观察指标:患者生存率,技术生存率和住院时间。结果:每周平均Kt / V尿素为1.9 +/- 0.8,每周肌酐清除率为62.9 +/- 8.5 L / 1.73 m2,平均血清白蛋白水平为3.7 +/- 0.6 g / dL。因死亡(12.6%),移植(3.9%),转移至血液透析(8.7%),患者适应性疾病(1.5%)和其他原因(93%)而退出腹膜透析的患者有93例(28%)。死亡的主要原因是心血管疾病(60%),感染(19%),恶性肿瘤(2%)和其他原因(19%)。 Cox比例风险模型分析表明年龄,血清白蛋白水平,合并症和功能状态影响生存和住院(p <0.05),而性别和Kt / V则无影响(p> 0.05)。通过Kaplan-Meier分析估计的患者存活率分别在1年,2年,3年和5年时分别为94.2%,88.6%,84.5%和68.9%。通过Kaplan-Meier分析得出的技术生存期分别为1年,2年,3年和5年,分别为96.6%,91.1%,90.4%和77.4%。结论:腹膜透析是土耳其可接受的肾脏替代疗法。关于Kt / V在预测死亡率和发病率方面的有效性存在争议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号